1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends

Global Markets for Bioengineered Protein Drugs

  • August 2014
  • 189 pages
  • BCC Research
Report ID: 2354690

Summary

Table of Contents

This BCC Research report explores the present and future strategies within the bioengineered protein drugs market. It analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares. Revenues are broken down by region. CAGR projections are estimated for the five-year period from 2014 through 2019. The report also covers significant patents and their allotments in each category.

Use this report to:
- Receive information about the current and future global market for bioengineered protein drugs.
- Receive information on diseases for which protein drugs are particularly amenable including hemophilia, diabetes, cancer, cystic fibrosis, hepatitis, psoriasis, and congenital
diseases.
- Analyze the industry structure of bioengineered protein drugs.
- Learn about the significant patents and their allotments in each category.

Highlights
- The global market for bioengineered protein drugs was valued at $151.9 billion in 2013 and will reach about $157.0 billion in 2014. The market is further expected to grow to about $222.7 billion in 2019, a compound annual growth rate (CAGR) of 7.2% from 2014 through 2019.
- The U.S. is the largest regional segment of the market; anticipated to be at $72 billion in 2014 and $111 billion by 2019, increasing at a CAGR of 9.1% from 2014 through 2019.
- The European region should reach $38.8 billion in 2014 and nearly $55.4 billion by 2019 at a 7.4% CAGR for the period 2014-2019.

INTRODUCTION

STUDY OBJECTIVES
Proteins play a crucial role in living organisms. They play an important part in defining both structure as well as function. In recent years, technology advances has led to the
development of advanced techniques for controlled and effective delivery of peptides and proteins in the body. This has led to their efficient use in treating human injury and effective targeted treatments to prevent a number of life-threatening diseases. Furthermore, these drugs are useful as preventive vaccinations, blood-clotting factors,
etc. The objective of this report is to provide an overview of the current and future global market for bioengineered protein drugs. The objective is to present a comprehensive analysis of the future direction of bioengineered protein drugs in terms of an important tool for the use of protein-based drugs.

This report explores the present and future strategies within the bioengineered protein drugs market. Drug categories included in this report are monoclonal antibodies,
cytokines, peptide hormones, therapeutic enzymes, vaccines, blood factors and peptide antibiotics. The inventiveness of the market, the setbacks and the needs of the
market are discussed in this report. Usage of these types of drugs in various disease sectors is also depicted in this report. Diseases for which protein drugs are particularly
responsive are also discussed in this report, and include diabetes, cancer, blood disorders and skin diseases, growth hormone disorder, enzyme disorder and fertility
disorder and others. A detailed analysis industry structure has been conducted. Revenues are broken down by region. Sales figures are estimated for the five-year period from 2014 through 2019. The report also covers significant patents and their allotments in each category.

REASONS FOR DOING THIS STUDY
The bioengineered protein drug market is one of the fastest growing markets in recent years in the overall pharmaceutical/biotechnology markets. These drugs have gained
much attention from pharmaceutical companies due to their bioreactivity, specificity, safety and overall success rate in treating disease. Extensive research in the field of
these protein drugs has revealed their usefulness in being able to provide therapeutic treatments for various diseases. R&D spending, along with increasing competition,
patent expiries and new technologies, are directing these drugs to a new direction. The progress in technology, as well as new product launches, has influenced market growth. Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of each type of bioengineered proteins in light of the new technologies, growing competition and changing customer needs.

INTENDED AUDIENCE
This study covers the areas of market growth in bioengineered protein drugs manufacturers and users. Pharmaceutical biotechnical companies, research institutes and physicians will find this study to be of interest.

SCOPE OF THE STUDY
The scope of this study involves the bioengineered protein therapeutics used in the pharmaceutical and the biopharmaceutical markets. BCC Research analyzes each
market and its applications, regulatory environment, technologies involved, market projections and market shares. The technological issues include all the latest trends,
pipeline products and developments. The emerging markets cover countries such as India, China, Japan, Korea, Taiwan, Africa, Australia, New Zealand, Canada, etc. The bioengineered protein drugs that are covered in this report are monoclonal antibodies, cytokines, peptide antibiotics, vaccines, enzymes, peptide hormones and blood factors. These products are bioengineered and are produced by recombinant DNA technology. The only blood products considered in this report are recombinant blood products which are derived through the recombinant DNA technology process.

METHODOLOGY
Both primary and secondary research methodologies were used in preparing this study. BCC Research conducted a comprehensive literature search, which included technical
newsletters and journals, and many other sources. Data were collected through interviews and correspondence with manufacturers of bioengineered protein drug experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Infectious Disease Testing Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 59500
  • Industry report
  • May 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

Virology and Bacteriology Testing Market 2021: A 68-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 59500
  • Industry report
  • June 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

Automated Microbiology Market 2021: A 68-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification

  • $ 52500
  • Industry report
  • June 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides granular data and analysis not available from any other published source. The survey is designed to help current suppliers and potential market ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.